JNJ vs ABBV — Key Metrics
| Metric | JNJ (JOHNSON & JOHNSON) | ABBV (ABBVIE INC) |
|---|---|---|
| Price | 264.74 | 261.59 |
| Market Cap | 638.0 Billion | 462.26 Billion |
| P/E (TTM) | 30.33 | 73.69 |
| P/B (Quarterly) | 7.353 | -72.404 |
| P/S (TTM) | 6.51 | 7.18 |
| Net Profit Margin (TTM) | 21.5 | 9.8 |
| Gross Margin (TTM) | 67.9 | 71.5 |
| ROE (TTM) | 25.7 | -135.7 |
| Revenue Growth YoY (TTM) | None | None |
Upfront Investment - S&P 500 Stock Comparison & AI Analysis
AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.
Performance Comparison
AI Model Recommendation
JNJ · JOHNSON & JOHNSON
Outperform
ABBV · ABBVIE INC
Outperform
Recommendation Summary
Both stocks are projected to outperform the market over the next year. If you have to make a choice, Upfront Recommendation: JNJ.
Financial Metrics
Prices delayed ~15 min
| JNJ | Metrics | ABBV |
|---|---|---|
| $264.74 | Price | $261.59 |
| — | Market Capitalization | — |
| 30.33 | Price to Earnings Ratio | 73.69 |
| 6.51 | Price to Sales | 7.18 |
| 28.68 | Price to FCF Ratio | 25.38 |
| 9.59 | Price to Gross Profit | 10.04 |
| 42.24 | Price to R&D | 47.59 |
| 10.67 | Price to Current Assets | 13.73 |